Growth and differentiation factor 15 is a biomarker for low back pain-associated disability.

In conclusion, we report for the first time, a significant and independent association between plasma GDF-15 concentrations and LBP-associated disability. Longitudinal studies are needed to determine whether GDF-15 could be a novel therapeutic target for prevention and/or treatment of LBP. PMID: 30776685 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30776685?dopt=Abstract

Source: Cytokine - February 15, 2019 Category: Molecular Biology Authors: Tarabeih N, Shalata A, Trofimov S, Kalinkovich A, Livshits G Tags: Cytokine Source Type: research